Date |
Product |
Disease |
Phase |
Company |
Therapeutic area |
2017-03-23
|
niraparib |
front-line ovarian cancer, lung cancer, breast cancer |
2,3 |
Tesaro (US - MA) |
Cancer - Oncology |
2017-03-22
|
nivolumab and tivozanib (N-{2-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-N´-(5-methyl-3-isoxazolyl) urea hydrochloride monohydrate) and Opdivo® (nivolumab) |
advanced renal cell carcinoma |
1-2 |
Aveo Oncology (USA - MA) |
Cancer - Oncology |
2017-03-22
|
GLPG3067 |
cystic fibrosis |
1 |
Galapagos (Belgium) AbbVie (USA - IL) |
Rare diseases - Genetic diseases |
2017-03-22
|
serelaxin - RLX030 |
acute heart failure |
3 |
Novartis (Switzerland) |
Cardiovascular diseases |
2017-03-21
|
MIN-102 (5-[4-[2-(5-(1-hydroxyethyl)-2-pyridinyl)ethoxy]benzyl]-2,4-thiazolidinedione hydrochloride) |
X-linked adrenoleukodystrophy |
1 |
Minoryx Therapeutics (Spain) |
Rare diseases - Genetic diseases |
2017-03-21
|
brilacidin |
ulcerative proctitis/ulcerative proctosigmoiditis |
2 |
Cellceutix (USA - MA), now Innovation Pharmaceuticals (USA - MA) |
Inflammatory diseases |
2017-03-20
|
nintedanib |
progressive fibrosing interstitial lung disease (PF-ILD) |
3 |
Boehringer Ingelheim (Germany) |
Lung diseases - Respiratory diseases |
2017-03-20
|
|
X-linked Myotubular Myopathy (XLMTM) |
|
Audentes Therapeutics (USA - CA) |
Rare diseases - Genetic diseases - Neuromuscular diseases |
2017-03-20
|
erymethionase (ERY-MET) |
|
preclinical |
Erytech Pharma (France) |
Cancer - Oncology |
2017-03-20
|
NKTR-181 |
patients with chronic low back pain who are also opioid-naïve |
3 |
Nektar Therapeutics (USA - CA) |
CNS diseases |
2017-03-20
|
SYNT002 |
|
preclinical |
Syntimmune (USA - MA) |
|
2017-03-17
|
Jardiance® (empagliflozin) |
chronic heart failure |
3 |
Boehringer Ingelheim (Germany) Eli Lilly (USA - IN) |
Cardiovascular diseases |
2017-03-17
|
RGX-501 |
homozygous familial hypercholesterolemia (HoFH) |
1-2 |
RegenXBio (USA - MD) |
Rare diseases - Genetic diseases - Metabolic diseases |
2017-03-16
|
Pollinex® Quattro Birch |
birch pollen induced seasonal allergic rhinitis |
3 |
Allergy Therapeutics (UK) |
Allergic diseases |
2017-03-15
|
VTS-270 (2-hydroxypropyl-?-cyclodextrin) |
Niemann-Pick disease type C1 |
2-3 |
Vtesse (USA - MD) |
Rare diseases - Genetic diseases |
2017-03-14
|
QGC001 |
|
preclinical |
Quantum Genomics (France) |
Cardiovascular diseases |
2017-03-13
|
AlloCSC-01 - allogeneic human cardiac stem cells (CSCs) |
acute myocardial infarction |
1-2 |
Coretherapix (Spain), now Tigenix (Belgium) |
Cardiovascular diseases |
2017-03-10
|
filgotinib |
small bowel Crohn's disease |
2 |
Galapagos (Belgium) Gilead Sciences (USA - CA) |
Digestive diseases - Gastrointestinal diseases - Inflammatory diseases |
2017-03-10
|
filgotinib |
fistulizing Crohn's disease |
2 |
Galapagos (Belgium) Gilead Sciences (USA - CA) |
Digestive diseases - Gastrointestinal diseases - Inflammatory diseases |
2017-03-09
|
SENS-111 |
acute vertigo |
2 |
Sensorion (France) |
|